CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 36 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,634,000 | -37.7% | 6,315,000 | -34.8% | 0.11% | -38.4% |
| Q1 2019 | $9,041,000 | +60.4% | 9,680,000 | +44.3% | 0.17% | +237.3% |
| Q4 2018 | $5,638,000 | -63.2% | 6,710,000 | -42.9% | 0.05% | -77.1% |
| Q1 2017 | $15,302,000 | -22.0% | 11,750,000 | -38.2% | 0.22% | -23.4% |
| Q4 2016 | $19,606,000 | +918.0% | 19,000,000 | +850.0% | 0.29% | +1064.0% |
| Q3 2016 | $1,926,000 | – | 2,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |